The mTORC2 subunit RICTOR drives breast cancer progression by promoting ganglioside biosynthesis through transcriptional and epigenetic mechanisms

Mohammad Nafees Ansari, Somesh K Jha, Ali Khan, Kajal Rajput, Nishant Pandey, Dolly Jain, Rajeshwari Tripathi, Nihal Medatwal, Pankaj Sharma, Sudeshna Datta, Animesh Kar, Trishna Pani, Sk Asif Ali, Kaushavi Cholke, Kajal Rana, Valiya P Snijesh, Geetashree Mukherjee, Suryanarayana V S Deo, Soumen Basak, Ashutosh Mishra, Jyothi S Prabhu, Arnab Mukhopadhyay, Avinash Bajaj and Ujjaini Dasgupta

PLOS Biology, 2025, vol. 23, issue 9, 1-35

Abstract: Sphingolipid and ganglioside metabolic pathways are crucial components of cell signaling, having established roles in cancer cell proliferation, invasion, and migration. However, regulatory mechanisms controlling sphingolipid and ganglioside biosynthesis in mammalian cells are less known. Here, we show that RICTOR, the regulatory subunit of mTORC2, regulates the synthesis of sphingolipids and gangliosides in human luminal breast cancer-specific MCF-7 and BT-474 cells through transcriptional and epigenetic mechanisms. We observe that RICTOR regulates glucosylceramide levels by modulating the expression of UDP-Glucose Ceramide Glucosyl transferase (UGCG). We identify Zinc Finger protein X-linked (ZFX) as a RICTOR-responsive transcription factor whose recruitment to the UGCG promoter is regulated by DNA methyltransferase 1 and histone demethylase (KDM5A), which are known AKT substrates. We further demonstrate that RICTOR regulates the synthesis of GD3 gangliosides through ZFX and UGCG, and triggers the activation of the EGFR signaling pathway, thereby promoting tumor growth. In line with our findings in human cell culture and mouse models, we observe an elevated expression of RICTOR, ZFX, and UGCG in Indian luminal breast cancer tissues and in TCGA and METABRIC datasets. Together, we establish a key regulatory circuit, RICTOR-AKT-ZFX-UGCG-Ganglioside-EGFR-AKT, and elucidate its contribution to breast cancer progression.Previous work has shown that the mTORC2 complex regulates lipid synthesis in cancer, but the underlying mechanisms are not fully understood. This study shows that RICTOR, the regulatory subunit of mTORC2, regulates the synthesis of sphingolipids and gangliosides by modulating the expression of the UGCG enzyme, thereby promoting breast cancer growth.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003362 (text/html)
https://journals.plos.org/plosbiology/article/file ... 03362&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pbio00:3003362

DOI: 10.1371/journal.pbio.3003362

Access Statistics for this article

More articles in PLOS Biology from Public Library of Science
Bibliographic data for series maintained by plosbiology ().